ALLVIA

Allvia is a South Korean biotechnology company specializing in the development and manufacture of advanced medical devices for the aesthetic medicine market. Founded in 2017, the company focuses on hyaluronic acid (HA) dermal fillers, utilizing its proprietary HICE (High-density Isopropyl Alcohol Cross-linking Enhancement) technology. This technology is designed to produce fillers with high viscoelasticity and stability while minimizing the use of chemical cross-linking agents like BDDE. Allvia's flagship product line, A-VIA, includes various formulations such as Fine, Deep, and Volume, tailored for specific aesthetic procedures including wrinkle correction and facial contouring. The company operates a GMP-certified manufacturing facility and has expanded its presence into international markets across Asia, Europe, and the Middle East.